Osteoporosis International

, Volume 14, Issue 7, pp 559–563 | Cite as

Assessment of bone mineral density in adults and children with Marfan syndrome

  • Philip F. Giampietro
  • Margaret Peterson
  • Robert Schneider
  • Jessica G. Davis
  • Cathleen Raggio
  • Elizabeth Myers
  • Stephen W. Burke
  • Oheneba Boachie-Adjei
  • Charles M. Mueller
Original Article

Abstract

Recent studies indicate that decreased bone mineral density (BMD) occurs in the spine, femoral necks and greater trochanters of some adults and children with Marfan syndrome. Because there is uncertainty regarding the BMD status of patients with Marfan syndrome, we undertook an analysis of BMD in both adults and children with Marfan syndrome. Dual energy X-ray absorptiometry analysis was performed on a convenience sample of 51 patients (30 adults and 21 children) with diagnosed Marfan syndrome from 1993 to 2000. T-Scores (i.e. the number of standard deviations above or below the average normal peak bone density) were determined for comparison of adults. Mean±SD of individual BMD values were used for comparison of the data of children. Compared to standard values obtained from normal adult patients, adult males with Marfan syndrome demonstrated significantly reduced femoral neck BMD with an average T-score of -1.54 (P<0.001), diagnostic of osteopenia. Although osteopenia and osteoporosis were observed in several middle aged and pre- and postmenopausal women, the average T-score value for adult females and children were within normal limits. The etiology and full significance of decreased BMD in adult male patients with Marfan syndrome remain uncertain at the present time. Our results lead us to question the value of aggressive BMD evaluations by DXA in these patients, particularly prior to reaching mid-age. Further investigations will be required to shed insights into the natural history of BMD in adults and children with Marfan syndrome. Any application of bone mineral replacement therapy such as bisphosphonate, selective estrogen receptor modulators, hormone replacement therapy and vitamin D in these patients may be premature based on the existing evidence.

Keywords

Adult males Femoral neck Marfan syndrome Osteopenia 

Notes

Acknowledgments

We acknowledge the Children's Clinical Research Center of Weill Medical College of Cornell University (GCRCMO1RR06020), Adult Clinical Research Center of Weill Medical College (M01RR00047) the John R. Cobb Scoliosis Research Fund and the assistance of Elizabeth Wood with construction of the database. We also appreciate the suggestions provided by Drs. David B. Schowalter and Christopher Bibbo. We also thank Marshfield Clinic Research Foundation for its support through the assistance of Alice Stargardt, Doreen Luepke, and Graig Eldred in the preparation of this manuscript.

References

  1. 1.
    Pyeritz RE, McKusick VA (1979) The Marfan syndrome: diagnosis and management. N Engl J Med 300:772–777PubMedGoogle Scholar
  2. 2.
    De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426CrossRefPubMedGoogle Scholar
  3. 3.
    Shores J, Berger KR, Murphy EA, Pyeritz RE (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 330:1335–1341CrossRefPubMedGoogle Scholar
  4. 4.
    Winter R (1987) Marfan's syndrome. In: Company WB (ed) Moe's textbook of scoliosis and other spinal deformities, 2nd edn. Saunders, Philadelphia, pp 554–560Google Scholar
  5. 5.
    Gray J, Bridges A, Mole P, Pringle T, Boxer M, Paterson C (1993) Osteoporosis and the Marfan syndrome. Postgrad Med J 69:373–375PubMedGoogle Scholar
  6. 6.
    Kohlmeier L, Gasner C, Marcus R (1993) Bone mineral status of women with Marfan syndrome. Am J Med 95:568–572PubMedGoogle Scholar
  7. 7.
    Tobias JH, Dalzell N, Child AH (1995) Assessment of bone mineral density in women with Marfan syndrome. Br J Rheumatol 34:516–519PubMedGoogle Scholar
  8. 8.
    Kohlmeier L, Gasner C, Bachrach LK, Marcus R (1995) The bone mineral status of patients with Marfan syndrome. J Bone Miner Res 10:1550–1555PubMedGoogle Scholar
  9. 9.
    Le Parc JM, Plantin P, Jondeau G, Goldschild M, Albert M, Boileau C (1999) Bone mineral density in sixty adult patients with Marfan syndrome. Osteoporos Int 10:475–479CrossRefPubMedGoogle Scholar
  10. 10.
    Carter N, Duncan E, Wordsworth P (2000) Bone mineral density in adults with Marfan syndrome. Rheumatology (Oxford) 39:307–309Google Scholar
  11. 11.
    Musgrave KO, Giambalvo L, Leclerc HL, Cook RA, Rosen CJ (1989) Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc 89:1484–1488PubMedGoogle Scholar
  12. 12.
    Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell, Oxford.Google Scholar
  13. 13.
    Jergas M, Genant HK (1993) Current methods and recent advances in the diagnosis of osteoporosis. Arth Rheum 36:1649–1662Google Scholar
  14. 14.
    Nelson DA, Koo WW (1999) Interpretation of absorptiometric bone mass measurements in the growing skeleton: issues and limitations. Calcif Tissue Int 65:1–3CrossRefPubMedGoogle Scholar
  15. 15.
    Maynard LM, Guo SS, Chumlea WC et al. (1998) Total-body and regional bone mineral content and areal bone mineral density in children aged 8–18 y: the Fels Longitudinal Study. Am J Clin Nutr 68:1111–1117PubMedGoogle Scholar
  16. 16.
    Tsipouras P, Del Mastro R, Sarfarazi M et al. (1992) Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med 326:905–909PubMedGoogle Scholar
  17. 17.
    Kielty CM, Shuttleworth CA (1995) Fibrillin-containing microfibrils: structure and function in health and disease. Int J Biochem Cell Biol 27:747–760Google Scholar
  18. 18.
    Dallas SL, Keene DR, Bruder SP et al. (2000) Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J Bone Miner Res 15:68–81PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  • Philip F. Giampietro
    • 1
    • 7
  • Margaret Peterson
    • 2
  • Robert Schneider
    • 3
  • Jessica G. Davis
    • 1
    • 2
  • Cathleen Raggio
    • 4
  • Elizabeth Myers
    • 2
  • Stephen W. Burke
    • 3
  • Oheneba Boachie-Adjei
    • 5
  • Charles M. Mueller
    • 6
  1. 1.Division of Genetics, Department of PediatricsWeill Medical College of Cornell UniversityNew YorkUSA
  2. 2.Department of BiomechanicsHospital for Special SurgeryNew YorkUSA
  3. 3.Department of RadiologyHospital for Special SurgeryNew YorkUSA
  4. 4.Department of Pediatric OrthopedicsHospital for Special SurgeryNew YorkUSA
  5. 5.Adult and Pediatric Spine SurgeryHospital for Special SurgeryNew YorkUSA
  6. 6.Division of Nutrition ResearchWeill Medical College of Cornell UniversityNew YorkUSA
  7. 7.Department of Medical Genetic ServicesMarshfield ClinicMarshfieldUSA

Personalised recommendations